Table 3.

Logistic regression for pathologic complete response by BRCA status and treatment.

BRCA status and treatment	Odds Ratio	95% Confidence Interval	p-value
BRCA Case vs. Matched Control	2.40	(0.72,7.95)	0.15
Arm A vs. C	4.55	(1.89,10.97	0.0007
Arm B vs. C	5.31	(1.92,14.66)	0.001
BRCA Case vs. Matched Control *Arm A vs. C	0.44	(0.10,1.84)	0.26
BRCA Case vs. Matched Control *Arm B vs. C	0.24	(0.04,1.24)	0.09

Arm A: Paclitaxel, carboplatin, veliparib followed by doxorubicin and cyclophosphamide.

Arm B: Paclitaxel, carboplatin followed by doxorubicin and cyclophosphamide.

Arm B: Paclitaxel followed by doxorubicin and cyclophosphamide.